BETHANY TRIANA: Open Payments
NPI 1568884047 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$957 in 45 payments from 17 companies in 2025. Trend: 2023 $1,250 · 2024 $895 · 2025 $957
Food & beverage: $858Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $288 |
| Novartis Pharmaceuticals Corporation | 11 | $209 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $94 |
| LEO Pharma Inc. | 3 | $59 |
| PFIZER INC. | 3 | $55 |
| Lilly USA, LLC | 2 | $43 |
| Galderma Laboratories, L.P. | 2 | $32 |
| Organogenesis Inc. | 1 | $28 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $25 |
| UCB, Inc. | 1 | $24 |
Products named: TREMFYA, COSENTYX, SPEVIGO, ADBRY, CIBINQO, TALTZ, NEMLUVIO, VIA MATRIX.
Industry payments across OK — which companies pay providers there.
